コンテンツへスキップ
Merck

I7642

Sigma-Aldrich

抗インターロイキン-12抗体 ヤギ宿主抗体

IgG fraction of antiserum

別名:

抗IL-12抗体

ログイン組織・契約価格を表示する


About This Item

MDL番号:
UNSPSCコード:
51111800
NACRES:
NA.41

由来生物

goat

品質水準

抗体製品の状態

IgG fraction of antiserum

抗体製品タイプ

primary antibodies

クローン

polyclonal

化学種の反応性

mouse

テクニック

neutralization: suitable
western blot: 1-2 μg/mL

UniProtアクセッション番号

保管温度

−20°C

ターゲットの翻訳後修飾

unmodified

遺伝子情報

mouse ... Il12a(16159)

詳細

Interleukin-12 (IL-12) is an important cytokine that links innate and adaptive immunity. It plays a role in the regulation of Th1-associated cellular immunity to foreign pathogens, and humoral immunity to antigens that are both T cell-independent and T cell-dependent. IL-12 is primarily produced by innate immune cells, dendritic cells, epithelial cells and macrophages. All forms of IL-12 bind to the IL-12R which includes IL-12RbI and IL-12RbII subunits expressed on T cells and natural cells. IL-12 stimulates the production of IFN-γ and TNF-α, subsequent production of nitric oxide that leads to pathogen destruction. Reports suggest the involvement of JAK/STAT pathway components in mediating these effects. The effects of IL-12 have been implicated in bacterial, fungal and viral infections. Due to its role in inducing matrix metalloproteases, it also has important role in the etiology of chronic B-cell malignancies and lung adenocarcinomas
Anti-Interleukin-12 antibody recognizes mouse IL-12. It shows < 10% cross-reactivity with recombinant human IL-12 and < 5% cross-reactivity with recombinant porcine IL-12.

特異性

本抗体はリコンビナントマウスIL-12の生物活性を中和します。ELISAによる抗体の交差反応性はリコンビナントヒトIL-12で約10%、リコンビナントブタIL-12では5%未満です。

免疫原

昆虫細胞株Sf21発現リコンビナントマウスIL-12の精製物。

アプリケーション

Anti-Interleukin-12 antibody may be used for immunoblotting at a working concentration of 1-2 μg/ml. The antibody is also suitable for neutralization reactions. It has been used to neutralize IL-12 in the extracts of murine splenocytes.

物理的形状

凍結乾燥品 (PBS溶液, 5%トレハロ-ス含有, 0.2μmフィルタ-滅菌済み)。

調製ノート

プロテインGを用いて精製しています。

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 製品選択ツール.

保管分類コード

11 - Combustible Solids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

I7642-1MG:
I7642-1MG-PW:
I7642-BULK:
I7642-VAR:


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Ludwig Deml et al.
Infection and immunity, 73(8), 4732-4742 (2005-07-26)
Predominant T-helper 1 (Th1) responses with increased gamma interferon (IFN-gamma) levels have been proposed to play an important role in Helicobacter pylori-induced gastritis and peptic ulceration. However, bacterial factors contributing to the initiation of Th1 polarization of H. pylori-specific immune
Dennis W Metzger
Cytokine, 52(1-2), 102-107 (2010-07-24)
Interleukin (IL)-12 is a pivotal cytokine that strongly stimulates Th1-associated cellular immunity. It is now recognized that IL-12 also activates humoral immunity to both T-dependent and T-independent antigens. This has let to considerable interest in exploiting IL-12 as a vaccine
Anne O'Garra et al.
Nature immunology, 10(9), 929-932 (2009-08-21)
The authors recount their discovery of how pathogen-induced interleukin 12 production leads to T(H)1 T cell polarization. Simultaneously they discovered the suppressive cytokine interleukin 10 inhibits antigen-presenting cells, thus regulating development of T(H)1 cells.
IL-12 and Related Cytokines: Function and Regulatory Implications in Candida albicans Infection
Ashman RB et al
Clinical & Developmental Immunology, doi: 10-doi: 10 (2011)
David J Klinke
Molecular cancer, 9, 242-242 (2010-09-17)
Monoclonal antibodies represent some of the most promising molecular targeted immunotherapies. However, understanding mechanisms by which tumors evade elimination by the immune system of the host presents a significant challenge for developing effective cancer immunotherapies. The interaction of cancer cells

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)